Agrawal, S. (2016). Treating tobacco dependence. Chronic Respiratory Disease, 13(2), 89.
Allen, S. S., Allen, A. M., & Pomerleau, C. S. (2009). Influence of phase-related variability in premenstrual symptomatology, mood, smoking withdrawal, and smoking behavior during ad libitum smoking, on smoking cessation outcome. Addictive Behaviors, 34(1), 107–111.
Andréen, L., Nyberg, S., Turkmen, S. van Wingen, G. Fernández, G., & Bäckström, T. (2009).
Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology, 34(8), 1121–1132.
Anstey, K. J., Sanden, C. von, Salim, A., & O’Kearney, R. (2007). Smoking as a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies. Journal of Epidemiology, 166(4), 367–378.
Aracri, P., Consonni, S., Morini, R., Perrella, M., Rodighiero, S., Amadeo, A., & Becchetti, A.
(2010). Tonic Modulation of GABA Release by Nicotine Acetylcholine Receptors in Layer V of the Murine Prefrontal Cortex. Cerebral Cortex, 20(7), 1539–1555.
Aron, A. R., Robbins, T. W., & Poldrack, R. A. (2004). Inhibition and the right inferior frontal cortex. Trends in Cognitive Sciences, 8(4), 170–177.
Baillie, A. J., Mattick, R. P., & Hall, W. (1995). Quitting smoking: estimation by meta-analysis of the rate of unaided smoking cessation. Australian Journal of Public Health, 19(2), 129–131.
Barnoya, J., & Glantz, S. A. (2005). Cardiovascular effects of secondhand smoke: Nearly as large as smoking. Circulation, 111(20), 2684–2698.
Bartos, M., Vida, I., & Jonas, P. (2007). Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nature Reviews Neuroscience, 8, 45–56.
Beauducel, A., Strobel, A., & Brocke, B. (2003). Psychometrische Eigenschaften und Normen einer deutschsprachigen Fassung der Sensation Seeking-Skalen, Form V. Diagnostica, 49(2), 36–47.
Becker, J., & Hu, M. (2008). Sex Differences in Drug Abuse. Frontiers in Neuroendocrinology, 29, 36–47.
Bell, L. A., Bell, K. A., & McQuiston, A. R. (2015). Acetylcholine release in mouse hippocampal CA1 preferentially activates inhibitory-selective interneurons via α4β2*
nicotinic receptor activation. Frontiers in Cellular Neuroscience, 9(115), 1–10.
Benowitz, N. L. (2008). Neurobiology of Nicotine Addiction: Implications for Smoking Cessation Treatment. The American Journal of Medicine, 121(4A), S3-S10.
Benowitz, N. L. (2010). Nicotine addiction. New England Journal of Medicine, 362(24), 2295–2303.
Benowitz, N. L., & Jacob, P. 3. (1985). Nicotine renal excretion rate influences nicotine intake during cigarette smoking. Journal of Pharmacology and Experimental Therapeutics, 234(1), 153–155.
oral contraceptive use accelerate nicotine metabolism. Clinical Pharmacology &
Therapeutics, 79(5), 480–488.
Bentley, P., Driver, J., & Dolan, R. J. (2011). Cholinergic modulation of cognition: Insights from human pharmacological functional neuroimaging. Progress in Neurobiology, 94(4), 360–388.
Berkman, E. T., Falk, E. B., & Lieberman, M. D. (2011). In the Trenches of Real-World Self-Control: Neural Correlates of Breaking the Link Between Craving and Smoking.
Psychological Science, 22(4), 498–506.
Bhandari, A. (2006). Anger and Cigarette Smoking. Journal of Indian Health Psychology, 1(1), 123–130.
Billieux, J., Gay, P., Rochat, L., Khazaal, Y., Zullino, D., & van der Linden, M. (2010). Lack of inhibitory control predicts cigarette smoking dependence: Evidence from a non-deprived sample of light to moderate smokers. Drug and Alcohol Dependence, 112(1-2), 164–167.
Bleich, S., Havemann-Reinecke, U., & Kornhuber, J. (2002). Fagerström-Test für Nikotinabhängigkeit (FTNA). Göttingen: Beltz Test GmbH.
Bolego, C., Poli, A., & Paoletti, R. (2002). Smoking and gender. Cardiovascular Research, 53, 568–576.
Bough, K. J., Lerman, C., Rose, J. E., McClernon, F. J., Kenny, P. J., Tyndale, R. F., . . . Conti, D. V. (2013). Biomarkers for smoking cessation. Clinical Pharmacology & Therapeutics, 93(6), 526–538.
Boy, F., Evans, C. J., Edden, R. A. E., Lawrence, A. D., Singh, K. D., Husain, M., & Sumner, P. (2011). Dorsolateral prefrontal γ-aminobutyric acid in men predicts individual
differences in rash impulsivity. Biological Psychiatry, 70(9), 866–872.
Boyle, P., Gandini, S., Robertson, C., Zatonski, W., Fagerstrom, K., Slama, K., . . . The International Smokers Survey Group. (2000). Characteristics of smokers’ attitudes towards stopping. European Journal of Public Health, 10(3), 5–14.
Brambilla, P., Perez, J., Barale, F., Schettini, G., & Soares, J. C. (2003). GABAergic dysfunction in mood disorders. Molecular Psychiatry, 8(8), 721–737.
Breslau, N., Kilbey, M. M., & Andreski, P. (1992). Nicotine Withdrawal Symptoms and Psychiatric Disorders: Findings From an Epidemiologic Study of Young Adults. The American Journal of Psychiatry, 149(4), 464–469.
Brickley, S. G., & Mody, I. (2012). Extrasynaptic GABAA Receptors: Their Function in the CNS and Implications for Disease. Neuron, 73(1), 23–34.
Brody, A. L., Mandelkern, M. A., London, E. D., Olmstead, R. E., Farahi, J., Scheibal, D., . . . Mukhin, A. G. (2006). Cigarette smoking saturates brain α4β2 acetylcholine receptors.
Archives of General Psychiatry, 63(8), 907–915.
Brown, R. M. (1992). The Basis Neurobiology of Addiction. In J. Frankenheim & R. M.
Brown (Eds.), Bioavailability of drugs to the brain and the blood-brain barrier (pp. 4-12).
Rockville: U. S. Department of Health and Human Services, Public Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Drug Abuse.
AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Archives of Internal Medicine, 158(16), 1789–1795.
Carpenter, M. J., Upadhyaya, H. P., LaRowe, S. D., Saladin, M. E., & Brady, K. T. (2006).
Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: A review.
Nicotine & Tobacco Research, 8(5), 627–638.
Carr, D. B., & Sesack, S. R. (2000b). Projections from the Rat Prefrontal Cortex to the Ventral Tegmental Area: Target Specificity in the Synaptic Associations with Mesoaccumbens and Mesocortical Neurons. The Journal of Neuroscience, 20(10), 3864–3873.
Carr, D. B., & Sesack, S. R. (2000a). GABA-Containing Neurons in the Rat Ventral Tegmental Area Project to the Prefrontal Cortex. Synapse, 38(2), 114–123.
Carroll, M. E., Lynch, W. J., R., M. E., Morgan, A. D., & Cosgrove, K. P. (2004). Sex and estrogen influence drug abuse. Trends in Pharmacological Science, 25(5), 273–279.
Carton, S., Houezec, J. L., Lagrue, G., & Jouvent, R. (2000). Relationships Between Sensation Seeking and Emotional Symptomatology During Smoking Cessation with Nicotine Patch Therapy. Addictive Behaviors, 25(5), 653–662.
Carton, S., Jouvent, R., & Widloecher, D. (1994). Sensation seeking, nicotine dependence, and smoking motivation in female and male smokers. Addictive Behaviors, 19(3), 219–
227.
Caverzasi, E., Pichiecchio, A., Poloni, G. U., Calligaro, A., Pasin, M., Palesi, F., . . . Bastianello, S. (2012). Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature. Functional Neurology, 27(1), 13–22.
Cepeda-Benito, A., Reynoso, J. T., & Erath, S. (2004). Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women.
Journal of Consulting and Clinical Psychology, 72(4), 712.
Chaiton, M., Diemert, L., Cohen, J. E., Bondy, S. J., Selby, P., Philipneri, A., & Schwartz, R.
(2016). Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers. BMJ Open, 6(6), [A53]. doi: 10.1136/bmjopen-2016-011045
Chambers, C. D., Garavan, H., & Bellgrove, M. A. (2009). Insights into the neural basis of response inhibition from cognitive and clinical neuroscience. Neuroscience &
Biobehavioral Reviews, 33(5), 631–646.
Chen, C.-M. A., Stanford, A. D., Mao, X., Abi-Dargham, A., Shungu, D. C., Lisanby, S. H., . . . Kegeles, L. S. (2014). GABA level, gamma oscillation, and working memory
performance in schizophrenia. NeuroImage: Clinical, 4, 531–539.
Chrzan, R., Tomaszuk, M., & Urbanik, A. (2013). The influence of the menstrual cycle on the result of brain examination with hydrogen magnetic resonance spectroscopy–a pilot study.
Neurologia I Neurochirurgia Polska, 47(5), 450–455.
Cosgrove, K. P., Mazure, C. M., & Staley, J. K. (2007). Evolving knowledge of sex
differences in brain structure, function, and chemistry. Biological Psychiatry, 62(8), 847–
855.
Mansvelder, H. D. (2007). Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex. Neuron, 54(1), 73–87.
Cousins, M. S., Stamat, H. M., & de Wit, H. (2001). Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking. Nicotine & Tobacco Research, 3(2), 123–129.
Cross, C. P., Copping, L. T., & Campbell, A. (2011). Sex differences in impulsivity: a meta-analysis. Psychological Bulletin, 137(1), 97.
Cross, C. P., Cyrenne, D.-L. M., & Brown, G. R. (2013). Sex differences in sensation-seeking:
a meta-analysis. Scientific Reports, 3(2486), 1–5.
Cyders, M. A., & Smith, G. T. (2008). Emotion-based dispositions to rash action: positive and negative urgency. Psychological Bulletin, 134(6), 807.
Czypionka, T., Pock, M., Röhrling, G., & Sigl, C. (2013). Volkswirtschaftliche Effekte der Alkoholkrankheit: Eine ökonomische Analyse für Österreich. Wien: Institut für Höhere Studien.
D’Souza, M. S., & Markou, A. (2013). The “stop” and “go” of nicotine dependence: role of GABA and glutamate. Cold Spring Harbor Perspectives in Medicine, 3(6), a012146.
Dajas-Bailador, F., & Wonnacott, S. (2004). Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends in Pharmacological Sciences, 25(6), 317–324.
De Biasi, M., & Dani, J. A. (2011). Reward, addiction, withdrawal to nicotine. Annual Review of Neuroscience, 34(1), 105–130.
De Bondt, T., De Belder, F., Vanhevel, F., Jacquemyn, Y., & Parizel, P. M. (2015). Prefrontal GABA concentration changes in women—influence of menstrual cycle phase, hormonal contraceptive use, and correlation with premenstrual symptoms. Brain Research, 1597, 129–138.
Dean, A. C., Sugar, C. A., Hellemann, G., & London, E. D. (2011). Is all risk bad? Young adult cigarette smokers fail to take adaptive risk in a laboratory decision-making test.
Psychopharmacology, 215(4), 801–811.
DeMartini, K. S., & Carey, K. B. (2012). Optimizing the use of the AUDIT for alcohol screening in college students. Psychological Assessment, 24(4), 954–963.
Diekhof, E. K., & Gruber, O. (2010). When desire collides with reason: functional
interactions between anteroventral prefrontal cortex and nucleus accumbens underlie the human ability to resist impulsive desires. Journal of Neuroscience, 30(4), 1488–1493.
Donny, E. C., Caggiula, A. R., Rowell, P. P., Gharib, M. A., Maldovan, V., Booth, S., . . . McCallum, S. (2000). Nicotine self-administration in rats: estrous cycle effects, sex differences and nicotinic receptor binding. Psychopharmacology, 151(4), 392–405.
dos Santos Coura, R., & Granon, S. (2012). Prefrontal neuromodulation by nicotinic receptors for cognitive processes. Psychopharmacology, 221(1), 1–18.
Druga, R. (2009). Neocortical inhibitory system. Folia Biologica (Praha), 55(6), 201–217.
Durazzo, T. C., Meyerhoff, D. J., Mon, A., Abé, C., Gazdzinski, S., & Murray, D. E. (2016).
Chronic cigarette smoking in healthy middle-aged individuals is associated with decreased
488.
Durazzo, T. C., Meyerhoff, D. J., & Nixon, S. J. (2010). Chronic cigarette smoking:
implications for neurocognition and brain neurobiology. International Journal of Environmental Research and Public Health, 7(10), 3760–3791.
Edden, R. A. E., Puts, N. A. J., Harris, A. D., Barker, P. B., & Evans, C. J. (2014). Gannet: A batch‐processing tool for the quantitative analysis of gamma‐aminobutyric acid–edited MR spectroscopy spectra. Journal of Magnetic Resonance Imaging, 40(6), 1445–1452.
Endres, D., van Tebartz Elst, L., Feige, B., Backenecker, S., Nickel, K., Bubl, A., . . . Perlov, E. (2016). On the effect of sex on prefrontal and cerebellar neurometabolites in healthy adults: an MRS study. Frontiers in Human Neuroscience, 10(367). doi:
10.3389/fnhum.2016.00367
Epperson, C. N., O’Malley, S., Czarkowski, K. A., Gueorguieva, R., Jatlow, P., Sanacora, G., . . . Mason, G. F. (2005). Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy. Biological Psychiatry, 57(1), 44–48.
European Union. (2017). Attitudes of Europeans towards tobacco and electronic cigarettes, Special Eurobarometer 458. Abrufbar auf
http://filterlos.at/fileadmin/user_upload/Eurobarometer_458_en.compressed.pdf.
Franklin, T. R., Harper, D., Kampman, K., Kildea-McCrea, S., Jens, W., Lynch, K. G., . . . Childress, A. R. (2009). The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study. Drug & Alcohol Dependence, 103(1-2), 30–36.
Fujiwara, H., Zheng, M., Miyamoto, A., & Hoshino, O. (2011). Insufficient augmentation of ambient GABA responsible for age-related cognitive deficit. Cognitive Processing, 12(2), 151–159.
Galanti, L. M., Manigart, P., & Dubois, P. (1998). Tobacco smoking and alcohol and drug consumption in a large, young healthy population. Archives of Environmental Health: an International Journal, 53(2), 156–160.
Galván, A., Poldrack, R. A., Baker, C. M., McGlennen, K. M., & London, E. D. (2011).
Neural correlates of response inhibition and cigarette smoking in late adolescence.
Neuropsychopharmacology, 36(5), 970–978.
Gangitano, D., Salas, R., Teng, Y., Perez, E., & De Biasi, M. (2009). Progesterone modulation of α5 nAChR subunits influences anxiety‐related behavior during estrus cycle. Genes, Brain and Behavior, 8(4), 398–406.
Ganji, S. K., An, Z., Banerjee, A., Madan, A., Hulsey, K. M., & Choi, C. (2014).
Measurement of regional variation of GABA in the human brain by optimized point‐
resolved spectroscopy at 7 T in vivo. NMR in Biomedicine, 27(10), 1167–1175.
Gao, F., Edden, R. A. E., Li, M., Puts, N. A. J., Wang, G., Liu, C., . . . Barker, P. B. (2013).
Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels. Neuroimage, 78, 75–82.
Current Issues in Pharmacy and Medical Science, 25(2), 212–217.
Gillies, G. E., Virdee, K., McArthur, S., & Dalley, J. W. (2014). Sex-dependent diversity in ventral tegmental dopaminergic neurons and developmental programing: a molecular, cellular and behavioral analysis. Neuroscience, 282, 69–85.
Goldstein, R. Z., & Volkow, N. D. (2011). Dysfunction of the prefrontal cortex in addiction:
neuroimaging findings and clinical implications. Nature Reviews Neuroscience, 12(11), 652.
Gomez, R., Behar, K. L., Watzl, J., Weinzimer, S. A., Gulanski, B., Sanacora, G., . . . Mason, G. F. (2012). Intravenous ethanol infusion decreases human cortical γ-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 tesla.
Biological Psychiatry, 71(3), 239–246.
Gorelova, N., Mulholland, P. J., Chandler, L. J., & Seamans, J. K. (2011). The glutamatergic component of the mesocortical pathway emanating from different subregions of the ventral midbrain. Cerebral Cortex, 22(2), 327–336.
Govindaraju, V., Young, K., & Maudsley, A. A. (2000). Proton NMR chemical shifts and coupling constants for brain metabolites. NMR in Biomedicine, 13(3), 129–153.
Greenfield, S. F., Back, S. E., Lawson, K., & Brady, K. T. (2010). Substance abuse in women.
Psychiatric Clinics of North America, 33(2), 339–355.
Greenhouse, I., Noah, S., Maddock, R. J., & Ivry, R. B. (2016). Individual differences in GABA content are reliable but are not uniform across the human cortex. Neuroimage, 139, 1–7.
Harada, M., Kubo, H., Nose, A., Nishitani, H., & Matsuda, T. (2011). Measurement of variation in the human cerebral GABA level by in vivo MEGA‐editing proton MR spectroscopy using a clinical 3 T instrument and its dependence on brain region and the female menstrual cycle. Human Brain Mapping, 32(5), 828–833.
Harris, A. D., Puts, N. A. J., & Edden, R. A. E. (2015). Tissue correction for GABA‐edited MRS: Considerations of voxel composition, tissue segmentation, and tissue relaxations.
Journal of Magnetic Resonance Imaging, 42(5), 1431–1440.
Harris, A. D., Saleh, M. G., & Edden, R. A. E. (2017). Edited 1H magnetic resonance spectroscopy in vivo: methods and metabolites. Magnetic Resonance in Medicine, 77(4), 1377–1389.
Harris, C. R., Jenkins, M., & Glaser, D. (2006). Gender differences in risk assessment: why do women take fewer risks than men? Judgment and Decision Making, 1(1), 48–63.
Hartwell, K. J., Johnson, K. A., Li, X., Myrick, H., LeMatty, T., George, M. S., & Brady, K. T.
(2011). Neural correlates of craving and resisting craving for tobacco in nicotine dependent smokers. Addiction Biology, 16(4), 654–666.
Hasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007).
Reduced prefrontal glutamate/glutamine and γ-aminobutyric acid levels in major
depression determined using proton magnetic resonance spectroscopy. Archives of General Psychiatry, 64(2), 193–200.
relationship between measures of impulsivity and risky simulated driving amongst young drivers. Accident Analysis & Prevention, 103, 37–43.
Hautzinger, M., Keller, F., & Kühner, C. (2006). BDI II–Beck Depressions-Inventar–Manual, 2. Auflage. Frankfurt: Pearson Assessment & Information.
Heishman, S. J., Kleykamp, B. A., & Singleton, E. G. (2010). Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology, 210(4), 453–469.
Herman, A. I., Waters, A. J., McKee, S. A., & Sofuoglu, M. (2012). Effects of pregabalin on smoking behavior, withdrawal symptoms, and cognitive performance in smokers.
Psychopharmacology, 220(3), 611–617.
Hiroi, N., & Agatsuma, S. (2005). Genetic susceptibility to substance dependence. Molecular Psychiatry, 10(4), 336–344.
Hughes, J. R. (2007). Effects of abstinence from tobacco: valid symptoms and time course.
Nicotine & Tobacco Research, 9(3), 315–327.
Janes, A. C., Jensen, J. E., Farmer, S. L., Frederick, B. D., Pizzagalli, D. A., & Lukas, S. E.
(2013). GABA levels in the dorsal anterior cingulate cortex associated with difficulty ignoring smoking-related cues in tobacco-dependent volunteers.
Neuropsychopharmacology, 38(6), 1113–1120.
Jasinska, A. J., Zorick, T., Brody, A. L., & Stein, E. A. (2014). Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans.
Neuropharmacology, 84, 111–122.
Jha, P., Peto, R., Zatonski, W., Boreham, J., Jarvis, M. J., & Lopez, A. D. (2006). Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America. The Lancet, 368(9533), 367–370.
Jupp, B., Caprioli, D., Saigal, N., Reverte, I., Shrestha, S., Cumming, P., . . . Dalley, J. W.
(2013). Dopaminergic and GABA‐ergic markers of impulsivity in rats: evidence for anatomical localisation in ventral striatum and prefrontal cortex. European Journal of Neuroscience, 37(9), 1519–1528.
Kalivas, P. W., & O'Brien, C. (2008). Drug addiction as a pathology of staged neuroplasticity.
Neuropsychopharmacology, 33(1), 166–180.
Kalivas, P. W., & Volkow, N. D. (2005). The neural basis of addiction: a pathology of motivation and choice. American Journal of Psychiatry, 162(8), 1403–1413.
Kalman, D., Morissette, S. B., & George, T. P. (2005). Co‐morbidity of smoking in patients with psychiatric and substance use disorders. The American Journal on Addictions, 14(2), 106–123.
Kandel, D. B., & Chen, K. (2000). Extent of smoking and nicotine dependence in the United States: 1991–1993. Nicotine & Tobacco Research, 2(3), 263–274.
Karama, S., Ducharme, S., Corley, J., Chouinard-Decorte, F., Starr, J. M., Wardlaw, J. M., . . . Deary, I. J. (2015). Cigarette smoking and thinning of the brain’s cortex. Molecular
Psychiatry, 20(6), 778–785.
correlation, causation, and context across stages of smoking. Psychological Bulletin, 129(2), 270–304.
Kühner, C., Bürger, C., Keller, F., & Hautzinger, M. (2007). Reliabilität und validität des revidierten beck-depressionsinventars (BDI-II). Der Nervenarzt, 78(6), 651–656.
Kumar, S., Porcu, P., Werner, D. F., Matthews, D. B., Diaz-Granados, J. L., Helfand, R. S., &
Morrow, A. L. (2009). The role of GABAA receptors in the acute and chronic effects of ethanol: a decade of progress. Psychopharmacology, 205(4), 529–564.
Kutlu, M. G., Parikh, V., & Gould, T. J. (2015). Nicotine addiction and psychiatric disorders.
In International review of neurobiology (pp. 171–208). Elsevier.
Lang, N., Hasan, A., Sueske, E., Paulus, W., & Nitsche, M. A. (2008). Cortical hypoexcitability in chronic smokers? A transcranial magnetic stimulation study.
Neuropsychopharmacology, 33(10), 2517–2523.
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H.
(2000). Smoking and mental illness: a population-based prevalence study. Journal of the American Medical Association, 284(20), 2606–2610.
Lauriola, M., Panno, A., Levin, I. P., & Lejuez, C. W. (2014). Individual differences in risky decision making: A meta‐analysis of sensation seeking and impulsivity with the balloon analogue risk task. Journal of Behavioral Decision Making, 27(1), 20–36.
Lee, J. J., Patel, R., Biermann, J. S., & Dougherty, P. J. (2013). The musculoskeletal effects of cigarette smoking. The Journal of Bone and Joint Surgery, 95(9), 850–859.
Lejuez, C. W., Aklin, W. M., Jones, H. A., Richards, J. B., Strong, D. R., Kahler, C. W., &
Read, J. P. (2003). The balloon analogue risk task (BART) differentiates smokers and nonsmokers. Experimental and Clinical Psychopharmacology, 11(1), 26.
Lejuez, C. W., Read, J. P., Kahler, C. W., Richards, J. B., Ramsey, S. E., Stuart, G. L., . . . Brown, R. A. (2002). Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART). Journal of Experimental Psychology: Applied, 8(2), 75–84.
Leshner, A. I. (1997). Addiction is a brain disease, and it matters. Science, 278(5335), 45–47.
Li, X., Semenova, S., D'Souza, M. S., Stoker, A. K., & Markou, A. (2014). Involvement of glutamatergic and GABAergic systems in nicotine dependence: implications for novel pharmacotherapies for smoking cessation. Neuropharmacology, 76, 554–565.
Li, Y., Yuan, K., Cai, C., Feng, D., Yin, J., Bi, Y., . . . Tian, J. (2015). Reduced frontal cortical thickness and increased caudate volume within fronto-striatal circuits in young adult smokers. Drug & Alcohol Dependence, 151, 211–219.
Lopez-Quintero, C., de los Cobos, J. P., Hasin, D. S., Okuda, M., Wang, S., Grant, B. F., &
Blanco, C. (2011). Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug & Alcohol Dependence, 115(1), 120–
130.
Lovick, T. A. (2008). GABA in the female brain—oestrous cycle-related changes in
GABAergic function in the periaqueductal grey matter. Pharmacology Biochemistry and Behavior, 90(1), 43–50.
behaviour? Neuroimaging and neuropsychological evidence of inhibitory dysregulation.
Addiction, 99(12), 1491–1502.
Luijten, M., Littel, M., & Franken, I. H. A. (2011). Deficits in inhibitory control in smokers during a Go/NoGo task: an investigation using event-related brain potentials. PloS One, 6(4), e18898.
Lynch, W. J., & Sofuoglu, M. (2010). Role of progesterone in nicotine addiction: evidence from initiation to relapse. Experimental and Clinical Psychopharmacology, 18(6), 451–
461.
Mackay, J., & Amos, A. (2003). Women and tobacco. Respirology, 8(2), 123–130.
Maguire, J., & Mody, I. (2007). Neurosteroid synthesis-mediated regulation of GABAA receptors: relevance to the ovarian cycle and stress. Journal of Neuroscience, 27(9), 2155–
2162.
Mansvelder, H. D., Keath, J. R., & McGehee, D. S. (2002). Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron, 33(6), 905–919.
Mansvelder, H. D., & McGehee, D. S. (2002). Cellular and synaptic mechanisms of nicotine addiction. Journal of Neurobiology, 53(4), 606–617.
Mansvelder, H. D., van Aerde, K. I., Couey, J. J., & Brussaard, A. B. (2006). Nicotinic modulation of neuronal networks: from receptors to cognition. Psychopharmacology, 184(3-4), 292–305.
Markou, A. (2008). Neurobiology of nicotine dependence. Philosophical Transactions of the Royal Society B: Biological Sciences, 363(1507), 3159–3168.
Méndez, D., Alshanqeety, O., & Warner, K. E. (2013). The potential impact of smoking control policies on future global smoking trends. Tobacco Control, 22(1), 46–51.
Mescher, M., Merkle, H., Kirsch, J., Garwood, M., & Gruetter, R. (1998). Simultaneous in vivo spectral editing and water suppression. NMR in Biomedicine, 11(6), 266–272.
Meule, A., Mayerhofer, M., Gründel, T., Berker, J., Beck Teran, C., & Platte, P. (2015). Half-year retest-reliability of the Barratt Impulsiveness Scale–short form (BIS-15). Sage Open, 5(1), 1-3.
Meule, A., Vögele, C., & Kübler, A. (2011). Psychometrische evaluation der deutschen Barratt impulsiveness scale–Kurzversion (BIS-15). Diagnostica, 57(3), 126–133.
Meyerhoff, D. J., Durazzo, T. C., & Ende, G. (2011). Chronic alcohol consumption,
abstinence and relapse: brain proton magnetic resonance spectroscopy studies in animals and humans. In W. Sommer & R. Spanagel (Eds.), Behavioral Neurobiology of Alcohol Addiction. Current Topics in Behavioral Neurosciences 13 (pp. 511–540). Heidelberg:
Springer.
Mikkelsen, M., Singh, K. D., Sumner, P., & Evans, C. J. (2016). Comparison of the repeatability of GABA‐edited magnetic resonance spectroscopy with and without macromolecule suppression. Magnetic Resonance in Medicine, 75(3), 946–953.
Mitchell, S. H. (2004). Measuring impulsivity and modeling its association with cigarette smoking. Behavioral and Cognitive Neuroscience Reviews, 3(4), 261–275.
GABAergic input to striatal neurons. Neuroreport, 17(5), 537–540.
Moeller, F. G., Barratt, E. S., Dougherty, D. M., Schmitz, J. M., & Swann, A. C. (2001).
Psychiatric aspects of impulsivity. American Journal of Psychiatry, 158(11), 1783–1793.
Moeller, S. J., London, E. D., & Northoff, G. (2016). Neuroimaging markers of glutamatergic and GABAergic systems in drug addiction: Relationships to resting-state functional
connectivity. Neuroscience & Biobehavioral Reviews, 61, 35–52.
Mon, A., Durazzo, T. C., & Meyerhoff, D. J. (2012). Glutamate, GABA, and other cortical metabolite concentrations during early abstinence from alcohol and their associations with neurocognitive changes. Drug & Alcohol Dependence, 125(1-2), 27–36.
Morissette, S. B., Tull, M. T., Gulliver, S. B., Kamholz, B. W., & Zimering, R. T. (2007).
Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships.
Psychological Bulletin, 133(2), 245–272.
Morphett, K., Partridge, B., Gartner, C., Carter, A., & Hall, W. (2015). Why don’t smokers want help to quit? A qualitative study of smokers’ attitudes towards assisted vs. unassisted quitting. International Journal of Environmental Research and Public Health, 12(6), 6591–
6607.
Mullins, P. G., McGonigle, D. J., O'Gorman, R. L., Puts, N. A. J., Vidyasagar, R., Evans, C. J.,
& Edden, R. A. E. (2014). Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. Neuroimage, 86, 43–52.
Nakajima, M., & al'Absi, M. (2012). Predictors of risk for smoking relapse in men and women: A prospective examination. Psychology of Addictive Behaviors, 26(3), 633.
Nashmi, R., Xiao, C., Deshpande, P., McKinney, S., Grady, S. R., Whiteaker, P., . . . Lester, H.
A. (2007). Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors:
basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path.
Journal of Neuroscience, 27(31), 8202–8218.
Ng, M., Freeman, M. K., Fleming, T. D., Robinson, M., Dwyer-Lindgren, L., Thomson, B., . . . Gakidou, E. (2014). Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA, 311(2), 183–192.
O'Dell, L. E., & Torres, O. V. (2014). A mechanistic hypothesis of the factors that enhance vulnerability to nicotine use in females. Neuropharmacology, 76(Part B), 566–580.
Oeltzschner, G., Schnitzler, A., Wickrath, F., Zöllner, H. J., & Wittsack, H.-J. (2016). Use of quantitative brain water imaging as concentration reference for J-edited MR spectroscopy of GABA. Magnetic Resonance Imaging, 34(8), 1057–1063.
O'Gorman, R. L., Michels, L., Edden, R. A. E., Murdoch, J. B., & Martin, E. (2011). In vivo detection of GABA and glutamate with MEGA‐PRESS: reproducibility and gender effects.
Journal of Magnetic Resonance Imaging, 33(5), 1262–1267.
Ohmura, Y., Takahashi, T., & Kitamura, N. (2005). Discounting delayed and probabilistic monetary gains and losses by smokers of cigarettes. Psychopharmacology, 182(4), 508–
515.
Penny, W. D., Friston, K. J., Ashburner, J. T., Kiebel, S. J., & Nichols, T. E. (2011). Statistical parametric mapping: the analysis of functional brain images: Elsevier.
self-administration: review of human and animal evidence. Nicotine & Tobacco Research, 1(4), 301–315.
Perkins, K. A., Doyle, T., Ciccocioppo, M., Conklin, C., Sayette, M., & Caggiula, A. (2006).
Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking. Psychopharmacology, 184(3-4), 600–607.
Perkins, K. A., Gerlach, D., Broge, M., Grobe, J. E., & Wilson, A. (2000a). Greater sensitivity to subjective effects of nicotine in nonsmokers high in sensation seeking. Experimental and Clinical Psychopharmacology, 8(4), 462–471.
Perkins, K. A., Gerlach, D., Vender, J., Meeker, J., Hutchison, S., & Grobe, J. (2001). Sex differences in the subjective and reinforcing effects of visual and olfactory cigarette smoke stimuli. Nicotine & Tobacco Research, 3(2), 141–150.
Perkins, K. A., Giedgowd, G. E., Karelitz, J. L., Conklin, C. A., & Lerman, C. (2012).
Perkins, K. A., Giedgowd, G. E., Karelitz, J. L., Conklin, C. A., & Lerman, C. (2012).